Statins Regulate Stem Cell Growth Factor‐β to Balance Osteogenesis and Adipogenesis in Mesenchymal Stem Cells, Endowing Anti‐Osteonecrosis Effects
Journal of Cellular and Molecular Medicine · 2025
DOI: 10.1111/jcmm.70967 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Cellular and Molecular Medicine, 2025. Verfasst von Fangzhou Fan und 11 weiteren Autor:innen. Beteiligte Einrichtung: Department of Orthopedics, Chongqing Municipal Health Commission Key Laboratory of Musculoskeletal Regeneration and Translational Medicine, the First…. Hauptthemen laut MEDLINE: Mesenchymal Stem Cells, Osteogenesis, Adipogenesis, Hydroxymethylglutaryl-CoA Reductase Inhibitors. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 50 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Research project of Fujian Medical University Union Hospital, The Science and Technology Research Project of Chongqing Education Commission, Doctoral Research Innovation Project of the First Affiliated Hospital of Chongqing Medical University.
Abstract (Originalsprache)
Dyslipidaemia has been implicated in osteonecrosis through some clinical studies. However, a direct causal relationship between hyperlipidaemia and osteonecrosis remains unconfirmed, and whether lipid‐lowering agents could be used to treat osteonecrosis remains unclear. This study aimed to investigate the causal role of lipid traits in osteonecrosis using Mendelian randomisation (MR) analysis, assess the potential effects and mechanisms of lipid‐lowering drug targets on osteonecrosis risk and validate these findings through experimental approaches. Genome‐wide association study (GWAS) data were used to analyse lipid traits, drug targets and FinnGen osteonecrosis. Statin effects were further studied in a rat model of steroid‐induced osteonecrosis and in vitro cell models. MR analysis revealed a significant association between LDL‐C and increased osteonecrosis risk. Genetic mimicry of HMGCR inhibitors was associated with reduced osteonecrosis risk, which was validated through colocalisation. Stem cell growth factor‐β (SCGF‐β) was identified as a mediator of 21.3% of HMGCR inhibitors' effect on osteonecrosis risk. Further studies confirmed simvastatin's alleviating effect on SONFH, suggesting that simvastatin promotes osteogenesis and inhibits adipogenesis of mesenchymal stem cells (MSCs), partly mediated by SCGF‐β upregulation, which activates the Wnt signalling pathway. Our findings supported dyslipidaemia as a causal factor for osteonecrosis, highlighting HMGCR as a promising therapeutic target.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Orthopedics, Chongqing Municipal Health Commission Key Laboratory of Musculoskeletal Regeneration and Translational Medicine, the First Affiliated Hospital of Chongqing Medical University, Chongqing, China.
- Chongqing Key Laboratory of Molecular Oncology and Epigenetics, Department of Breast and Thyroid Surgery, The First Affiliated Hospital of Chongqing Medical University, Chongqing, China.
- Department of Geriatrics, The First Affiliated Hospital of Chongqing Medical University, Chongqing, China.
- Department of Orthopaedics, Sports Injury Division, Fujian Medical University Union Hospital, Fuzhou, China.
ORCID-Profile: Qian Xiao, Chengjie Lian
Förderung
- Research project of Fujian Medical University Union Hospital
- The Science and Technology Research Project of Chongqing Education Commission
- Doctoral Research Innovation Project of the First Affiliated Hospital of Chongqing Medical University
- Chongqing Natural Science Foundation
- Fujian Provincial Natural Science Foundation of China
- The Graduate Advisor Team Project of the First Affiliated Hospital of Chongqing Medical University
- Chongqing medical scientific research project-Joint project of Chongqing Health Commission and Science and Technology Bureau
- Future Medical Youth Innovation Team Project of Chongqing Medical University
Zitieren
APA
Fan, F., Chen, Y., Peng, W., Yan, W., Tan, H., Zhang, C., Tan, S., Xiao, Q., Gao, Y., Zhang, J., Liu, L., & Lian, C. (2025). Statins Regulate Stem Cell Growth Factor‐β to Balance Osteogenesis and Adipogenesis in Mesenchymal Stem Cells, Endowing Anti‐Osteonecrosis Effects. Journal of Cellular and Molecular Medicine. https://doi.org/10.1111/jcmm.70967
Vancouver
Fan F, Chen Y, Peng W, Yan W, Tan H, Zhang C, et al. Statins Regulate Stem Cell Growth Factor‐β to Balance Osteogenesis and Adipogenesis in Mesenchymal Stem Cells, Endowing Anti‐Osteonecrosis Effects. Journal of Cellular and Molecular Medicine. 2025. doi:10.1111/jcmm.70967
BibTeX
@article{Fan2025,
author = {Fan, Fangzhou and Chen, Yu and Peng, Weiyan and Yan, Wenlong and Tan, Hao and Zhang, Chengxuan and Tan, Siyu and Xiao, Qian and Gao, Yuan and Zhang, Jian and Liu, Lei and Lian, Chengjie},
title = {Statins Regulate Stem Cell Growth Factor‐β to Balance Osteogenesis and Adipogenesis in Mesenchymal Stem Cells, Endowing Anti‐Osteonecrosis Effects},
journal = {Journal of Cellular and Molecular Medicine},
year = {2025},
doi = {10.1111/jcmm.70967}
}
EUVIMED